Stock Earnings

Question 1

What are BioNexus Gene Lab Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), BioNexus Gene Lab Corp has a total asset of $10, Net loss of $-1

Question 2

What are the key financial ratios for BGLC?

Accepted Answer

BioNexus Gene Lab Corp's Current ratio is 5, has a Net margin is -11.11, sales per share of $5.05.

Question 3

How is BioNexus Gene Lab Corp's revenue broken down by segment or geography?

Accepted Answer

BioNexus Gene Lab Corp largest revenue segment is Trading of Industrial Chemicals, at a revenue of 9,494,577 in the most earnings release.For geography, Malaysia is the primary market for BioNexus Gene Lab Corp, at a revenue of 7,455,906.

Question 4

Is BioNexus Gene Lab Corp profitable?

Accepted Answer

no, according to the latest financial statements, BioNexus Gene Lab Corp has a net loss of $-1

Question 5

Does BioNexus Gene Lab Corp have any liabilities?

Accepted Answer

yes, BioNexus Gene Lab Corp has liability of 2

Question 6

How many outstanding shares for BioNexus Gene Lab Corp?

Accepted Answer

BioNexus Gene Lab Corp has a total outstanding shares of 1.79

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	9	9	9	10	13	11
Revenue Growth (YoY)	0%	0%	-10%	-23%	18%	--
Cost of Revenue	8	8	8	9	11	9
Gross Profit	1	1	1	1	2	1
Selling, General & Admin	5	3	4	1	1	1
Research & Development	--	0	0	--	--	--
Operating Expenses	4	2	3	1	1	0
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-3	-1	-2	0	1	1
Income Tax Expense	0	0	0	0	0	0
Net Income	-2	-1	-2	0	0	1
Net Income Growth	0%	-50%	--	--	-100%	--
Shares Outstanding (Diluted)	1.79	1.78	1.58	1.44	1.42	0.85
Shares Change (YoY)	2%	12%	10%	1%	66%	19%
EPS (Diluted)	-1.63	-0.9	-1.66	-0.24	0.52	1.27
EPS Growth	31%	-46%	592%	-146%	-59%	-474%
Free Cash Flow	-3	-2	-1	0	0	0
Free Cash Flow Per Share	-1.66	-1.12	-0.62	0	0	0
Gross Margin	11.11%	11.11%	11.11%	10%	15.38%	9.09%
Operating Margin	-22.22%	-11.11%	-22.22%	0%	7.69%	9.09%
Profit Margin	-22.22%	-11.11%	-22.22%	0%	0%	9.09%
Free Cash Flow Margin	-33.33%	-22.22%	-11.11%	0%	0%	0%
EBITDA	-2	-1	-2	0	1	1
EBITDA Margin	-22.22%	-11.11%	-22.22%	0%	7.69%	9.09%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-2	-1	-2	0	1	1
EBIT Margin	-22.22%	-11.11%	-22.22%	0%	7.69%	9.09%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

BioNexus Gene Lab Corp (BGLC) Price

BGLC Stock Price Chart

BGLC Income

Follow-Up Questions